| 产品详情 |
| Edit |   |
| Product Name | CD300a/LMIR1 Recombinant Protein Antigen |
| Description | Purity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 24 kDa. The CD300a/LMIR1 Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The CD300a/LMIR1 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition. |
| Size | 0.1 ml |
| Concentration | n/a |
| Applications | Antibody Competition |
| Other Names | CD300a antigenCMRF35H9, CD300a molecule, CLM-8, CMRF-35H, CMRF35-H, CMRF35H leukocyte immunoglobulin-like receptor, CMRF35-H9, CMRF-35-H9CD300 antigen-like family member A, CMRF35HIRp60, CMRF35-like molecule 8, IgSF12, IGSF12NK inhibitory receptor, Immunoglobulin superfamily member 12, Inhibitory receptor protein 60, IRC1, IRC1/IRC2, IRC2, Irp60, leukocyte membrane antigen |
| Gene, Accession, CAS # | CD300A, Gene ID: 11314 |
| Catalog # | NBP1-84431PEP |
| Price | |
| Order / More Info | CD300a/LMIR1 Recombinant Protein Antigen from NOVUS BIOLOGICALS, LLC |
| Product Specific References | n/a |
| 产品资料 |
|
|